1 / 19

Rare Disease Testing Market Latest News and Industry Growth Outlook

According to MarkNtel Advisors, the Rare Disease Testing Market is anticipated to grow at a CAGR of around 9.29% during the forecast period 2021-26.

Sonu22
Download Presentation

Rare Disease Testing Market Latest News and Industry Growth Outlook

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. www.marknteladvisors.com Global Rare Disease Testing Research Report: Forecast (2021-2026)

  2. Market Segmentation Global Rare Disease Testing Market • By Acquisition • Genetic • Externally Acquired • By Region • North America • The US • Canada • Mexico • South America • Brazil • Argentina • Others • Europe • Germany • France • The UK • Italy • Spain • Others • Asia Pacific • China • Japan • Singapore • India • Australia • Others • Middle East and Africa • GCC • Israel • Others • By Type • Cardiovascular • Ophthalmological • Neurological • Oncological • Hematological • Endocrine and Metabolism • Gastroenterologist • Others • By Company • Quest Diagnostics Inc. • Centogene N.V. • Invitae Corporation. • 3billion, Inc. • Arup Laboratories. • Eurofins Scientific. • Strand Life Sciences. • Ambry Genetics. • Color Genomics, • Health Network Laboratories • PreventionGenetics • Progenity, Inc. • Myriad Genetics, Inc. • Laboratory Corporation of America Holdings • OPKO Health, Inc. • By Technology • Next Generation Sequencing • Complete Genome • Complete Exome • Micro Arrays • Others • By End User • Hospitals • Diagnostics Laboratories • Clinical Labs • Contract Research Organizations • By Sample Type • DNA • Blood • Buccal Swab • Saliva • Others • By Products • Kits & Assays • Panels • Others • By Test Type • Genetic • General Lab Test • Imaging Test • Others • By Age Group • 0-15 yrs. • 16-30 yrs. • 31-45 yrs. • Others

  3. Study Background – Project Outline (1/16)

  4. Study Background – Project Outline (2/16)

  5. Study Background – Project Outline (3/16)

  6. Study Background – Project Outline (4/16)

  7. Study Background – Project Outline (5/16)

  8. Study Background – Project Outline (6/16)

  9. Study Background – Project Outline (7/16)

  10. Study Background – Project Outline (8/16)

  11. Study Background – Project Outline (9/16)

  12. Study Background – Project Outline (10/16)

  13. Study Background – Project Outline (11/16)

  14. Study Background – Project Outline (12/16)

  15. Study Background – Project Outline (13/16)

  16. Study Background – Project Outline (14/16)

  17. Study Background – Project Outline (15/16)

  18. Study Background – Project Outline (16/16)

More Related